Cardiovascular Systems VP Sells $95,977 in Stock (CSII)
Cardiovascular Systems (NASDAQ:CSII) VP Kevin Kenny unloaded 4,182 shares of the company’s stock in a transaction that occurred on Wednesday, October 16th. The shares were sold at an average price of $22.95, for a total transaction of $95,976.90. Following the completion of the sale, the vice president now directly owns 104,026 shares in the company, valued at approximately $2,387,397. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
CSII has been the subject of a number of recent research reports. Analysts at Benchmark Co. initiated coverage on shares of Cardiovascular Systems in a research note to investors on Tuesday, September 10th. They set a “speculative buy” rating and a $26.00 price target on the stock. Separately, analysts at Feltl & Co. upgraded shares of Cardiovascular Systems from a “buy” rating to a “strong-buy” rating in a research note to investors on Thursday, August 8th. They now have a $27.50 price target on the stock, up previously from $19.50. Finally, analysts at Wunderlich initiated coverage on shares of Cardiovascular Systems in a research note to investors on Friday, July 26th. They set a “buy” rating and a $24.00 price target on the stock. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $26.30.
Cardiovascular Systems (NASDAQ:CSII) traded up 0.52% during mid-day trading on Friday, hitting $23.00. The stock had a trading volume of 182,311 shares. Cardiovascular Systems has a one year low of $10.38 and a one year high of $23.75. The stock’s 50-day moving average is $20.61 and its 200-day moving average is $20.17. The company’s market cap is $572.8 million.
Cardiovascular Systems (NASDAQ:CSII) last posted its quarterly earnings results on Wednesday, August 7th. The company reported ($0.28) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.30) by $0.02. The company had revenue of $28.80 million for the quarter, compared to the consensus estimate of $27.18 million. Analysts expect that Cardiovascular Systems will post $-1.14 EPS for the current fiscal year.
Cardiovascular Systems, Inc (NASDAQ:CSII) is a medical device company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.